« Back
Home /
Brivanib (alaninate)

Brivanib (alaninate)

Manufacturer	TargetMol
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	1 mL
Item no.	TMO-T2576-1mL
CASRN	649735-63-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Short Description	Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
Shipping	cool pack
Storage	-20°
Target names or alias	BMS-582664 , Brivanib Alaninate
Molecular Weight	441, 46
Pathway	Autophagy\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors
Target	VEGFR\|\|\|FGFR\|\|\|Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mL

available

Delivery expected until 6/21/2024